Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Effect of Pharmacoprophylaxis on Postoperative Outcomes in Adult Elective Colorectal Surgery: A Multi-Center Retrospective Cohort Study within an Enhanced Recovery after Surgery Framework

Version 1 : Received: 20 October 2023 / Approved: 23 October 2023 / Online: 23 October 2023 (15:34:14 CEST)

A peer-reviewed article of this Preprint also exists.

Blair, W.O.; Ellis, M.A.; Fada, M.; Wiggins, A.A.; Wolfe, R.C.; Patel, G.P.; Brockhaus, K.K.; Droege, M.; Ebbitt, L.M.; Kramer, B.; Likar, E.; Petrucci, K.; Shah, S.; Taylor, J.; Bingham, P.; Krabacher, S.; Moon, J.H.; Rogoz, M.; Jean-Jacques, E.; Cleary, R.K.; Eke, R.; Findley, R.; Parrish, R.H., II. Effect of Pharmacoprophylaxis on Postoperative Outcomes in Adult Elective Colorectal Surgery: A Multi-Center Retrospective Cohort Study within an Enhanced Recovery after Surgery Framework. Healthcare 2023, 11, 3060. Blair, W.O.; Ellis, M.A.; Fada, M.; Wiggins, A.A.; Wolfe, R.C.; Patel, G.P.; Brockhaus, K.K.; Droege, M.; Ebbitt, L.M.; Kramer, B.; Likar, E.; Petrucci, K.; Shah, S.; Taylor, J.; Bingham, P.; Krabacher, S.; Moon, J.H.; Rogoz, M.; Jean-Jacques, E.; Cleary, R.K.; Eke, R.; Findley, R.; Parrish, R.H., II. Effect of Pharmacoprophylaxis on Postoperative Outcomes in Adult Elective Colorectal Surgery: A Multi-Center Retrospective Cohort Study within an Enhanced Recovery after Surgery Framework. Healthcare 2023, 11, 3060.

Abstract

Background: Application of enhanced recovery after surgery principles decrease postoperative complications (POCs), length of stay (LOS), and readmissions. Pharmacoprophylaxis decreases morbidity, but the effect of specific regimens on clinical outcomes is unclear. Methods and Materials: Records of 476 randomly selected adult patients who underwent elective colorectal surgeries (ECRS) at 10 US hospitals were abstracted. Primary outcomes were surgical site infection (SSI), venous thromboembolism (VTE), postoperative nausea and vomiting (PONV), pain, and ileus rates. Secondary outcomes included LOS and 7- and 30-day readmission rates. Results: POC rates were SSI (3.4%), VTE (1.5%), PONV (47.9%), pain (58.1%), and ileus (16.1%). Cefazolin 2g/metronidazole 500mg and ertapenem 1g were associated with the shortest LOS; cefotetan 2g and cefoxitin 2g with the longest LOS. No SSI occurred with ertapenem and cefotetan. More Caucasians than Blacks received oral antibiotics before intravenous antibiotics without impact. Enoxaparin 40 mg subcutaneously daily was the most common inpatient and discharge VTE prophylaxis. All in-hospital VTEs occurred with unfractionated heparin. Most received rescue rather than around the clock antiemetics. Scopolamine patch, spinal opioids, and IV lidocaine continuous infusion were associated with lower PONV. Transversus abdominis plane block with long-acting local anesthetics, celecoxib, non-anesthetic ketamine bolus, ketorolac IV, lidocaine IV, and pregabalin were associated with lower in-hospital pain severity rate. Gabapentinoids and alvimopan were associated with lower ileus rate. Acetaminophen, alvimopan, famotidine, and lidocaine patch were associated with shorter LOS. Conclusions: Significant differences in pharmacotherapy regimens that may improve primary and secondary outcomes in ECRS were identified. Future research should identify latent pharmacotherapy variables that impact patient outcomes.

Keywords

enhanced recovery; ileus; outcomes, postoperative; pain, postoperative; pharmacotherapy; postoperative nausea and vomiting; prophylaxis; surgical site infection; surgery, colorectal; venous thromboembolism

Subject

Medicine and Pharmacology, Pharmacy

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.